Abbott’s Cologuard Plus® receives CE Mark for colorectal cancer screening in Europe
ABBOTT PARK, Ill., , Oct. 20, 2026 /PRNewswire/ — Abbott, a global healthcare leader, announced today that the Cologuard Plus® test has received CE Mark under the European Union’s In Vitro Diagnostic
